December 4, 2023 Non Regulatory Nomination Committee appointed for the Annual General Meeting 2024 in LIDDS
July 7, 2023 Non Regulatory Interview with LIDDS’s Chairman of the Board published on the company’s website
May 2, 2023 Non Regulatory LIDDS participates in LSX World Congress and ERLIG Therapeutic Oligo meetings
March 14, 2023 Non Regulatory LIDDS participates in BIO-Europe Spring and EACR Immuno-Oncology Meetings
January 23, 2023 Non Regulatory The subscription period in LIDDS’ rights issue is starting today and the CEO has participated in an interview with Erik Penser Bank
January 9, 2023 Non Regulatory LIDDS signs a deal with Alira Health on sell-side support in Licensing